Immunotherapy for Patients with Unresectable Stage III Non-Small Cell Lung Cancer Following Chemoradiation Therapy
Treating patients with unresectable Stage III NSCLC requires a multidisciplinary approach, with the radiation oncologist playing a pivotal role in the treatment pathway. This interactive, case-based presentation will review the patient journey for Stage III NSCLC, from diagnosis to chemoradiation treatment and available options for improving patient outcomes following the completion of chemoradiation therapy.
Contact: Christina Mahon
The asset you are trying to access is locked. Please enter your access key to unlock.